Latest News and Press Releases
Want to stay updated on the latest news?
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} BOUSSARD...
-
ü Acquisition highlights Optimal fit with Solvay Novecare's products, technologies, customers and geographies, leading to significant share of fast-growing $8 billion U.S. oil & gas...
-
Polarcus Limited ("Polarcus" or the "Company") (OSE: PLCS) announces the Company's Third Quarter 2013 vessel utilization as follows: Q3 - 2013 Q3 - 2012 Full year 2012 Contract...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KONE Corporation, press release, October 7,...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Louvain-La-Neuve, Belgium, 7 October, 2013 -...
-
Zurich / Switzerland, 7 October 2013 The ARYZTA AG Annual Report and Accounts 2013 are now available for download from the ARYZTA website: www.aryzta.com. ...
-
Utveckling av NAV och aktiekurs * NAV per aktie den 30 september 2013 uppgick till 9,03 EUR (78 SEK) * NAV per aktie (EUR) ökade med 0,7 % (oförändrat i SEK) jämfört med den 31 augusti 2013 ...
-
NAV and share price development * NAV per share on 30 September 2013 amounted to EUR 9.03 (SEK 78) * NAV per share (EUR) increased by 0.7% (unchanged in SEK) compared to 31 August 2013 *...
-
TORONTO, ONTARIO--(Marketwired - Oct. 7, 2013) - Black Iron Inc. ("Black Iron" or the "Company") (TSX:BKI) (FRANKFURT:BIN) has received approval from Serbia's Commission for the...
-
NOVATO, Calif., Oct. 6, 2013 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc., a biotechnology company, announced the release of data from a first-in-human, randomized, double-blind,...